Biogen Inc (BIIB)

[blue finch]

The small print says there could
Be some brain swelling in up to 10% of the population
That’s not what the FDA will look too kindly at
And it won’t be he first time a
Major bio company gets a late stage drug denied approval and the we all know what happens to the share price then
Wait and see